Summary: We have developed a kinetic fixed-time approach for the quantitative determination of serum glucose by use of the hexokinase/glucose-6-phosphate dehydrogenase method. To achieve a large measuring range, we have apparently increased the Michaelis constant of glucose-6-phosphate dehydrogenase through addition of the competitive inhibitor ATP. By this means, serum samples with glucose concentrations up to 55.5 mmol/1 could be analyzed without pre-dilution. The method has been adapted to the ENI GEMSAEC analyzer and to the LKB 2086 Mark II analyzer. It yielded satisfactory results with regard to precision. A comparison of the kinetic procedure with the manual end-point method showed good agreement. No interferences from hemoglobin, bilirubin, or lipemia have been observed. 
Introduction
The assay is commonly carried out as an end-point procedure (1 ,2) . To improve the convenience of the Due to its specificity and its inserisitivity to interference, method for the autO mated clinical laboratory, we the hexokinase/glucose-6-phosphate dehydrogenase studied the f easi buity of a kinetic fixed-time approach method has found worldwide acceptance as a reference which allpws redu ction of the reaction time and omission method for the determination of glucose in body fluids of the technically elaborate determination of the initial (1). It is based on the following reaction sequence in absorbance (3) . which the second step is responsible for the high specific city of the assay (2) .
Because of the low Michaelis constant of glucose-6-phosphate dehydrogenase with respect to glucose-6-Hexokinase phosphate (4), the kinetic glucose assay using this en-Z>-Glucose + ATP gc ·> />-Glucose-6-phosphate + ADP Z yme and hexokinase is not, at first sight, suited for the determination of high glucose concentrations (3). Ho wGiucose-6-P ever, following the theory of Michaelis andMenten, this the additi°n °f » ----(EC 1. 
Samples
The sera used in the experiments were from patients. High glucose concentrations were obtained by adding various amounts of glucose to a human serum pool. Control sera were all from Boehringer Mannheim.
Procedures

GEMSAEC
The adjustment of the GEMSAEC system was as follows: Rotoloader: sample-switch, B; blank-switch, water; sample volume, 5 μΐ; flush volume, 150 μΐ (physiological saline diluent); reagent volume, 500 μΐ. The reagent was pipetted into well C of the transfer disk. 
Other procedures
The manual assays were carried out in 1 cm cuvettes at 25 °C and at Hg 365 nm. For measuring the activity of glucose-6-phosphate dehydrogenase in the presence of varying ATP concentrations, 2 ml of the assay mixture and 20 μΐ of glucose-6-phosphate-solution were used. The reaction was started by addition of glucose-6-phosphate. For determining the type of inhibition, the initial rates were measured and their reciprocal values plotted vs. the reciprocal substrate concentrations.
Results and Discussion
At present, in commercially available test kits for the determination of glucose according to the hexokinase end-point procedure, the glucose-o^phosphate dehydrogenase from Leycpriostoc mesenteroides is commonly used. This enzyme is known to be inhibited by pyridoxalphosphate (6), ATP and acyl-CoA derivatives (7). Stimulated by the fact that ATP is already employed as lowpriced and stable competitive inhibitor for the kinetic determination of serum triglycerides (8) we preferably looked into the suitability of that substance for the kinetic glucose assay.
To determine the type of inhibition of glucose^phos-phate dehydrogenase by ATP, we first studied the kinetics of this enzymatic reaction in the presence of increasing amounts of ATP. The results of the experiments are shown in figure 1, using a Lineweaver^Burk plot (9) . As indicated by the common point of inter? section of the curves on the 1/v axis, ATP exerts a competitive type of inhibition with respect to glucose-6-phosphate.
This finding suggested to us that, for the kinetic glucose assay, the K m -value of glucose-6-phosphate dehydrogen se could be increased by simply elevating the ATP concentration usually employed for the end-point method. An ATP concentration of about 17 nimol/l in the reaction mixture was calculated to cause the required shift of the Michaelis constant (3). Figure 2 demonstrates that under these conditions, after a short lag phase, the overall reaction of the glucose assay followed pse do-first-order kinetics with respect to glucose concentration. This, however, is known to be the basic requirement for a kinetic substrate determination by use of the fixed-time procedure (3) to exist between the fixed-time absorbance changes and the respective glucose concentrations. Furthermore, the figure demonstrates that the sensitivity of the assay was sufficiently high in the normal range of glucose. With the LKB 2086 Mark II method, the measuring range was found to extend up to 44.4 mmol/1 glucose.
Precision Table 1 lists the within-run precision of the present method. The data were obtained by simultaneous analysis of aliquots of calibration standard, normal and supranormal human sera. Day-to-day precision was studied for six days by repeated analysis of the control serum Precinorm U (Boehringer Mannheim). Satisfactory results were obtained with both methods; GEMSAEC: mean = 5.45 mmol/1, CV = 2.5 %; LKB 2086 Mark II: Mean = 5.38 mmol/1, CV = 3.4 %.
Tab. 1. Within-run precision of present method. Measuring range and sensitivity
We assayed dilutions of stock solution of high purity Dĝ lucose giving concentrations between 2.78 and 55.5 mmol/1. Figure 3 shows the results obtained with the GEMSAEC method. A straight line relationship was found Similar correlations between the kinetic methods and the endpoint method were observed using plasma samples (EDTA, heparin, citrate).
Interferences
As illustrated in table 2, colored blood components did not interfere with the kinetic method. The samples used in this experiment were taken from a human serum pool and different amounts of bilirubin or hemoglobin were added. Also no interference was observed from lipemia.
Conclusions
The present study shows that the reference method for the determination of glucose, the hexokinase/glucose-6-phosphate dehydrogenase method, can be carried out kinetically over a wide range of glucose concentration if appropriate assay conditions are used. The kinetic approach, however, is especially suited for automated instruments. It allows a short reaction time. Neither analysis of reagent or sample blanks nor determination of initial absorbances is needed.
